schliessen

Filtern

 

Bibliotheken

722.

Costs of first-line doublet chemotherapy and lifetime medical care in advanced non-small-cell lung cancer in the United States.
by Lang, Kathleen

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, June 2009, Vol.12(4), pp.481-488

723.

Cost-effectiveness analysis of docetaxel (Taxotere) vs. 5-fluorouracil in combined therapy in the initial phases of breast cancer.
by Martín-Jiménez, M

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, January 2009, Vol.11(1), pp.41-47

728.

Editorial: Does a Clinical Trial Warrant an Economic Analysis?
by Hillner, Bruce

Journal of the National Cancer Institute, May 20, 1998, Vol.90(10), pp.724-5

732.

Costs associated with diffuse large B-cell lymphoma patient treatment in a Canadian integrated cancer care center
by Lee, Robert C

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2008, Vol.11(2), pp.221-30

733.

Across generations: cancer treatment in developing countries.
by Aziz, Zeba

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, October 20, 2008, Vol.26(30), pp.4990-4991

740.

Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix.
by Paton, F

Health technology assessment (Winchester, England), May 2010, Vol.14 Suppl 1, pp.55-62

Recommended databases

Find more Articles matching your search terms in these recommended databases.

Filter electronic articles 855 Hits